Erasca, Inc. ERAS 深 沪
等待开盘 04-02 09:30:00 美东时间
16.60
+0.420
+2.60%
华盛通- 最 高16.81
- 今 开16.38
- 成交量 524.14万股
- 最 低 16.11
- 昨 收 16.18
- 总市值 51.59亿
- 52周最高 16.81
- 市盈率 静 --
- 换手率 1.69%
- 52周最低 1.06
- 委 比 -49.31%
- 总股本 3.11亿
- 历史最高 24.47
- 量 比 1.03
- 振 幅 4.33%
- 历史最低 1.01
- 每 手 1
- 风险率 4.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
US stocks rise, Dow Jones gains 600+ pts. Apellis Pharma shares surge 136.4% after buyout by Biogen for $41/share. Other gainers incl. Centessa, Annexon, Agios, Fulcrum, Scholar Rock, Alkermes, Wave Life, Perimeter Solutions, Praxis Precision, and Century Aluminum.
03-31 21:57
美股大行评级 | 超多下调！露露乐蒙、Oklo、腾讯音乐、Docusign、BOBS、Bicycle、Academy Sports等遭多家大行下调目标价
今日重点评级关注：花旗：维持Candel Therapeutics"买入"评级，目标价从22美元升至26美元；Chardan Capital：维持CervoMed"买入"评级，目标价从15美元升至21美元
03-19 14:31
美股大行评级 | 能源股获大行青睐！美国铝业、康索尔能源、康菲石油、EOG能源等获上调目标价；多只航空股遭下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Altimmune"买入"评级，目标价从12美元升至25美元；BTIG：维持Jade Biosciences"买入"评级，目标价从28美元升至39美元
03-17 11:45
美股大行评级 | 韦德布什升美光科技目标价升至500美元，维持"跑赢大市"评级
今日重点评级关注：Piper Sandler：维持Allogene疗法"超配"评级，目标价从7美元升至8美元；B. Riley证券：维持Oncology Institute"买入"评级，目标价从6美元升至8美元
03-16 18:19
FTAI Aviation To Rally More Than 43%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed outlook on top names: Adobe cut to $280, ServiceTitan to $100, KinderCare cut to $1.5, Nio upgraded to $6.8, Esperion raised to $5, Flagstar raised to $16, Nerdwallet cut to $9, Erasca raised.
03-13 20:09
HC Wainwright & Co. Maintains Buy on Erasca, Raises Price Target to $20
HC Wainwright & Co. analyst Andres Y. Maldonado maintains Erasca (NASDAQ:ERAS) with a Buy and raises the price target from $15 to $20.
03-13 19:15
Erasca Q4 EPS $(0.10), Inline
Erasca (NASDAQ:ERAS) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. This is a 9.09 percent increase over losses of $(0.11) per share from the same period last year.
03-13 04:08
美股大行评级 | 潜在涨幅183%！迈威尔科技获10家机构上调目标价最高至164美元；伯灵顿百货、好市多、Ciena、Samsara等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持BridgeBio Oncology"买入"评级，目标价从27美元升至29美元；韦德布什：维持WAVE Life Sciences"跑赢大市"评级，目标价从33美元升至35美元
03-09 11:47
Clear Street Maintains Buy on Erasca, Raises Price Target to $20
Clear Street analyst Kaveri Pohlman maintains Erasca (NASDAQ:ERAS) with a Buy and raises the price target from $11 to $20.
03-06 18:10
Erasca Secures U.S. Patent Titled Heterocyclic Substituted Pyrimidopyran Compound And Use Thereof
The issued patent provides intellectual property protection for ERAS-4001 and related compositions until at least 2043Expands Erasca's diversified IP portfolio for RAS-driven cancersInitial Phase 1 monotherapy data
02-24 21:02
